BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1704822)

  • 21. Secondary prophylactic G-CSF (filgrastim) administration in chemotherapy of stage I and II Hodgkin's lymphoma with ABVD.
    Rueda A; Sevilla I; Gumà J; Ribelles N; Miramón J; De Las Nieves MA; Márquez A; Alba E
    Leuk Lymphoma; 2001 Apr; 41(3-4):353-8. PubMed ID: 11378548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between the formation of O6-methyldeoxyguanosine by 1-p-carboxyl-3,3-dimethylphenyltriazene in DNA and O6-alkylguanine-DNA alkyltransferase in human peripheral leukocytes.
    Lee SM; O'Connor PJ; Thatcher N; Crowther D; Margison GP; Cooper DP
    Cancer Res; 1994 Aug; 54(15):4072-6. PubMed ID: 8033139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
    Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors.
    Gerson SL; Trey JE; Miller K; Benjamin E
    Cancer Res; 1987 Jan; 47(1):89-95. PubMed ID: 3539320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assay by inhibition of repair to measure O6-methylguanine in DNA.
    Mironov NM; Martel-Planche G; Wild CP
    Environ Mol Mutagen; 1994; 23(2):110-5. PubMed ID: 8143697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of Hodgkin's disease with ABVD].
    Montserrat E; Carreras E; Rozman C; Olivé T; Bladé J; Cervantes F; Feliu E; Gardella S; Grañena A; Marín P
    Med Clin (Barc); 1984 Dec; 83(18):739-41. PubMed ID: 6084157
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of rat liver O6-alkylguanine-DNA alkyltransferase following whole body X-irradiation.
    Schmerold I; Wiestler OD
    Cancer Res; 1986 Jan; 46(1):245-9. PubMed ID: 3509992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
    Diehl V; Franklin J; Hasenclever D; Tesch H; Pfreundschuh M; Lathan B; Paulus U; Sieber M; Rueffer JU; Sextro M; Engert A; Wolf J; Hermann R; Holmer L; Stappert-Jahn U; Winnerlein-Trump E; Wulf G; Krause S; Glunz A; von Kalle K; Bischoff H; Haedicke C; Duehmke E; Georgii A; Loeffler M
    J Clin Oncol; 1998 Dec; 16(12):3810-21. PubMed ID: 9850026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of N7-methylguanine in DNA of white blood cells from cancer patients treated with dacarbazine.
    van Delft JH; van den Ende AM; Keizer HJ; Ouwerkerk J; Baan RA
    Carcinogenesis; 1992 Jul; 13(7):1257-9. PubMed ID: 1638694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
    J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of rat liver O6-alkylguanine-DNA alkyltransferase by bleomycin.
    Schmerold I; Spath A
    Chem Biol Interact; 1986 Dec; 60(3):297-304. PubMed ID: 2431800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repair of O6-methylguanine and O4-methylthymidine in F344 rat liver following treatment with 1,2-dimethylhydrazine and O6-benzylguanine.
    O'Toole SM; Pegg AE; Swenberg JA
    Cancer Res; 1993 Sep; 53(17):3895-8. PubMed ID: 8358714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II study.
    Middleton MR; Lee SM; Arance A; Wood M; Thatcher N; Margison GP
    Int J Cancer; 2000 Nov; 88(3):469-73. PubMed ID: 11054678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
    Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group.
    Fryer CJ; Hutchinson RJ; Krailo M; Collins RD; Constine LS; Hays DM; Heller RM; Davis PC; Nachman J; O'Brien RT
    J Clin Oncol; 1990 Dec; 8(12):1971-80. PubMed ID: 1700080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model.
    Wedge SR; Porteous JK; Newlands ES
    Cancer Chemother Pharmacol; 1997; 40(3):266-72. PubMed ID: 9219512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
    Chisesi T; Bellei M; Luminari S; Montanini A; Marcheselli L; Levis A; Gobbi P; Vitolo U; Stelitano C; Pavone V; Merli F; Liberati M; Baldini L; Bordonaro R; Pesce EA; Federico M
    J Clin Oncol; 2011 Nov; 29(32):4227-33. PubMed ID: 21990405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.